ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Vir Biotechnology, Inc. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 22 studies whose lead sponsor is Vir Biotechnology, Inc. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Vir Biotechnology with Mirum Pharmaceuticals and Sinovac Biotech →

Pipeline: 3 programs

Each counted once: 3 with a study Vir Biotechnology, Inc. leads registered in the last two years.

  • Phase 1
  • Phase 3

The 2 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Vir Biotechnology, Inc.’s own registered studies; Vir Biotechnology, Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Vir Biotechnology, Inc.’s studies test, most studies first; none is open now — 3 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

1 of Vir Biotechnology, Inc.’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 22 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now29%
  • Under way, not recruiting418%
  • Completed1255%
  • Stopped early314%
  • Status unknown or other15%

Phase

  • Phase 111
  • Phase 210
  • Phase 34

Where

  • United States14
  • United Kingdom8
  • Romania7
  • New Zealand6
  • Germany6
  • France6

Over the years

  1. 18
  2. 19
  3. 20
  4. 21
  5. 522
  6. 23
  7. 24
  8. 25
  9. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Vir Biotechnology, Inc.

  • Vir Biotechnology, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    22 studies

Studies

Recruiting first, then most recently updated. Showing 22 of 22.